article thumbnail

Bubble Wrap PLUS – June 2023

Don't Forget the Bubbles

2023 May;182(5):2077-2088. 2023 Jun;59(6):786-793. 2023 May 13. 2023 May 12:fetalneonatal-2022-324935. 2023 May 10. 2023 May;38(5):1411-1425. 2023 May;182(5):1965-1976. 2023 May;38(5):1449-1458. 2023 May;182(5):2027-2039. 2023 May 1;151(5):e2022058846. 2023 May 4;28(2):102-106.

article thumbnail

Bubble Wrap PLUS – May 2023

Don't Forget the Bubbles

2023 Apr 17. 2023 Apr 25;329(16):1386-1398. 2023 Apr 29. 2023 Apr 24. 2023 Apr 12. 2023 Apr 28. 2023 Apr 25. 2023 Apr 25. 2023 Apr 25. 2023 Apr 24. 2023 Apr 18:S0890-8567(23)00185-5. 2023 Apr 24. 2023 Apr 21. 2023 Apr 20:fetalneonatal-2022-324835.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2023 AHA Update on ACLS

EMDocs

Author: Brit Long, MD (@long_brit) // Reviewed by Alex Koyfman, MD (@EMHighAK) The American Heart Association 2023 Guideline Updates for 2023 were just published. Magnesium does not improve ROSC, survival, or neurologic outcomes, no matter the presenting rhythm (Level 3: no benefit). 2023 Dec 18. Circulation.

article thumbnail

Policy Playbook: Fall 2023 Updates

EMDocs

Additionally, a 2022 study in JAMA found no association between MIPS measures and any meaningful clinical outcomes and moreover physicians who cared for the most medically and socially vulnerable were more likely to receive worse scores (8). References American Medical Association. ” from [link] Seidenwurm, D. Burleson (2014).

article thumbnail

My Top Stories in Cardiology for 2023

Stop and Think

My Choice for Top Cardiology Story of 2023 Obesity Treatments: Here is what I wrote : Hyperbole is almost impossible when describing the potential benefits of the glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide reduced cardiovascular outcomes in patients with established cardiovascular disease and obesity but without diabetes.

article thumbnail

Can acetaminophen improve outcomes in sepsis?

PulmCCM

The ASTER Trial Ware et al conducted a phase 2b randomized trial from 2021 to 2023 among 447 patients admitted with sepsis and organ failure at 40 US academic hospitals. Patients received either 1 g of acetaminophen IV every six hours or placebo for five days.

Sepsis 52
article thumbnail

First10EM Journal Club: April 2023

Broome Docs

2023 Jan 21. 2023 Feb;64:206.e1-206.e3. Renal outcomes following intravenous contrast administration in patients with acute kidney injury: a multi-site retrospective propensity-adjusted analysis. 2023 Jan 30. 2023 Jan 13;76(2):185-191. 2023 Feb;30(2):144-146. 2023 Jan 17;329(3):224-234. N Engl J Med.

Sepsis 52